Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2011
09/29/2011WO2010127152A3 Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
09/29/2011US20110237792 Quinoline derivatives and their use as 5-ht6 ligands
09/29/2011US20110237776 Aromatic compounds with sulfur containing ligands
09/29/2011US20110237599 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/29/2011US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
09/29/2011US20110237580 Substituted bicyclic imidazole derivatives as gamma secretase modulators
09/29/2011US20110237576 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having bace1-inhibiting activity
09/29/2011US20110237575 Inhibitors of fatty acid binding protein (fabp)
09/29/2011US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/29/2011US20110237570 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
09/29/2011US20110237567 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
09/29/2011US20110237565 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/29/2011US20110237564 Imidazopyrimidine derivatives
09/29/2011US20110237517 Iap inhibitors
09/29/2011DE102010013068A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices
09/29/2011CA2794153A1 Chemical compounds
09/29/2011CA2794003A1 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use
09/29/2011CA2792339A1 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
09/29/2011CA2786900A1 Pyrrolopyrazine kinase inhibitors
09/29/2011CA2786402A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors
09/29/2011CA2786213A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors
09/28/2011EP2368876A1 Derivatives of aminoindanes, their preparation and their application in therapeutics
09/28/2011EP2367829A1 Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound
09/28/2011EP2367828A1 Process for the preparation of tetrazine derivatives
09/28/2011EP2367827A1 3-(3-pyrimidine-2-yl-benzyl)-ý1,2,4¨triazolo ý4,3-b¨pyridazine derivatives
09/28/2011EP2367820A2 Novel antimicrobials
09/28/2011EP2367598A2 Inhibitors of diacylglycerol acyltransferase
09/28/2011EP2367431A1 Organic compounds
09/28/2011EP2367430A1 Organic compounds
09/28/2011EP2367429A1 Organic compounds
09/28/2011EP2367428A1 Organic compounds
09/28/2011EP2041137B1 Pyrrolopyrimidines for pharmaceutical compositions
09/28/2011EP2041131B1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition
09/28/2011EP1620525B1 Organic electroluminescent device and platinum compound
09/28/2011EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors
09/28/2011CN1980661B Cationic bacteriochlorophyll derivatives and uses thereof
09/28/2011CN102203098A Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors
09/28/2011CN102203097A Novel tricyclic chiral compounds and their use in asymmetric catalysis
09/28/2011CN102203096A Compounds that expand hematopoietic stem cells
09/28/2011CN102203067A Hedgehog pathway modulators
09/28/2011CN102203063A Carbazole compounds and therapeutic uses of the compounds
09/28/2011CN102201540A Organic electroluminescence component
09/28/2011CN102199153A Method for preparing sodium copper chlorophyllin by using silkworm excrement as raw material
09/28/2011CN102199152A Heterocycle imidazoles phosphatide kinases inhibitor
09/28/2011CN102199116A Fluoro imido sugar compounds, and preparation method and application thereof
09/28/2011CN102199102A Sitagliptin intermediate and preparation method and application thereof
09/28/2011CN101759699B Pyrro-perhydroazepinone compound and application thereof in preparing medicaments for treating tumors
09/28/2011CN101544644B Preparation method of mianserin hydrochloride
09/27/2011US8026358 Process for preparing porphyrin derivatives, such as protoporphyrin (IX) and synthesis intermediates
09/27/2011US8026264 Triazole derivatives as inhibitors of 11-β hydroxysteroid dehydrogenase-1
09/27/2011US8026234 Polo-like kinase inhibitors
09/27/2011US8025988 Reactive organometallic dendrimers
09/27/2011CA2611750C Red-shifted water-dispersible naphthalocyanine dyes
09/27/2011CA2503646C Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
09/27/2011CA2487748C Composition for dyeing keratinous fibres containing at least one derivative of diamino-n,n-dihydropyrazolone
09/27/2011CA2415847C Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
09/22/2011WO2011116371A2 Polyplex gene delivery vectors
09/22/2011WO2011115813A1 Lactam acetamides as calcium channel blockers
09/22/2011WO2011114275A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes
09/22/2011WO2011114160A1 Anagrelide derivatives (imidazo [2, 1-b] quinazolin - 2 - ones ) as pde iii inhibitors useful as antithrombotic agents
09/22/2011WO2011114148A1 4h- [1, 2, 4] triazolo [5, 1 -b] pyrimidin-7 -one derivatives as ccr2b receptor antagonists
09/22/2011WO2011114109A1 Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3 -methyl-4,10-dihydro-3h-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide
09/22/2011WO2011113862A1 Imidazopyrazines
09/22/2011WO2011113606A1 Anti-infective compounds
09/22/2011WO2011113399A1 Method of preparing sitagliptin
09/22/2011WO2011080510A8 Tricyclic compounds for use as kinase inhibitors
09/22/2011WO2011071360A3 Synthesis of 8-aminoboron-dipyrromethenes having blue fluorescence
09/22/2011WO2009111653A3 Antiviral therapeutic agents
09/22/2011US20110230658 Process for the preparation of tetrazine derivatives
09/22/2011US20110230508 Novel Forms of a Fused Pyrrolocarbazole Compound
09/22/2011US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
09/22/2011US20110230476 Pi3 kinase inhibitors and uses thereof
09/22/2011US20110230472 Ring-fused azole derivative having pi3k-inhibiting activity
09/22/2011US20110230468 Fused heterocyclic compounds and uses thereof
09/22/2011US20110230465 Viral polymerase inhibitors
09/22/2011US20110230464 Purine derivatives useful as p13 kinase inhibitors
09/22/2011US20110230462 Pyrrolopyrazine Kinase Inhibitors
09/22/2011US20110230459 Lactam acetamides as calcium channel blockers
09/22/2011US20110230414 Pyrrolopyrazine Kinase Inhibitors
09/22/2011CA2793663A1 Polyplex gene delivery vectors
09/22/2011CA2793641A1 Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3 -methyl-4,10-dihydro-3h-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide
09/22/2011CA2793279A1 Imidazopyrazines
09/22/2011CA2793181A1 Nanotubes and compositions thereof
09/22/2011CA2793125A1 New enzyme inhibitor compounds
09/22/2011CA2793086A1 Anti-infective compounds
09/22/2011CA2791737A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes
09/21/2011EP2365970A1 Pyridazinones and their use as btk inhibitors
09/21/2011EP2365748A1 Imidazoisoindole neuropeptide s receptor antagonists
09/21/2011EP1966202B1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
09/21/2011EP1675860B1 Imidazo[1,5-a]pyrazines as tyrosine kinase inhibitors
09/21/2011EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase
09/21/2011CN102197038A Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
09/21/2011CN102190669A Dihydro pteridinone derivatives, preparation method thereof and application thereof in medicines
09/21/2011CN102190660A N-F Troger type quaternary ammonium salt and preparation method thereof
09/21/2011CN102190659A Phenylpyrazine compounds, and preparation method and medicinal application thereof
09/21/2011CN102190621A N-heterocyclyl-phenylsubstituierte cyclische ketoenole
09/20/2011US8022295 Photoelectric conversion devices
09/20/2011US8022207 Compound having affinity to amyloid
09/20/2011US8022083 Antiviral phosphonate analogs
09/20/2011US8022075 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition